CBID Recent News
Current News
Dr. Michael Wang, CBID Pilot Project investigator, speaks about the Lab2Market Accelerator
Orozco lab overturns the idea that a “risk gene” carried by millions of people influences production of Type 1 interferon in the immune system.
A new paper from the University of Kansas overturns the idea that a “risk gene” carried by millions of people worldwide influences production of Type 1 interferon, a workhorse of the immune system. ...
Fehr research shows human gene PARP14 could be novel target for viral diseases or immune-mediated disorders
Researchers at the University of Kansas have discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body’s innate immune system. Their study, appearing in journal mBio, could guide development of antiviral therapies for several groups of viral infection. ...
Dr. Robin Orozco, CBID Research Project Leader
Dr. Robin Orozco is an Assistant Professor at the University of Kansas, where her lab studies how specific allelic variants affect immune responses. She talks about what we can learn from mouse models and the role of PTPN22 in antiviral immunity. (36:48)...